Saeki, Hidehisa http://orcid.org/0000-0002-1095-0355
Ohya, Yukihiro
Baba, Naoko
Imamura, Tomomi
Yokota, Daisuke
Tsubouchi, Hidetsugu http://orcid.org/0000-0002-2926-4603
Clinical trials referenced in this document:
Documents that mention this clinical trial
An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis
https://doi.org/10.1007/s13555-024-01236-7
Funding for this research was provided by:
Otsuka Pharmaceutical
Article History
Received: 28 March 2024
Accepted: 10 July 2024
First Online: 29 July 2024
Declarations
:
: Hidehisa Saeki received grants from AbbVie, Eisai Co., Ltd., LEO Pharma K.K., Maruho Co., Ltd., Taiho Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., and Tokiwa Pharmaceutical Co., Ltd., and honoraria from AbbVie, Eli Lilly Japan K.K., Japan Tobacco Inc., LEO Pharma K.K., Maruho Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., Taiho Pharmaceutical Co., Ltd., Pfizer Japan Inc., Amgen Inc., and Torii Pharmaceutical Co., Ltd. Yukihiro Ohya received grants from Fam Pharma, Kao, and Maruho Co., Ltd., consulting fees from AbbVie, Eli Lilly Japan K.K., LEO Pharma K. K., Maruho Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Sanofi K.K., and honoraria from AbbVie, Mitsubishi Tanabe Pharma Corporation, Pfizer, Pola Pharma Inc., Sanofi K.K., Sinopharm, Taiho Pharmaceutical Co., Ltd., Thermo Fisher Scientific, and Torii Pharmaceutical Co., Ltd. Naoko Baba received honoraria from Otsuka Pharmaceutical Co., Ltd., Maruho Co., Ltd., and Torii Pharmaceutical Co., Ltd. Tomomi Imamura, Daisuke Yokota, Hidetsugu Tsubouchi, Toshiya Oka, Tomoyo Takayama, Ayaka Soga, Yu Takeuchi, Daisaku Michikami, Takahiro Tsuchiya, and Hiroe Takeda are employees of Otsuka Pharmaceutical Co., Ltd.
: This study received approval by the respective institutional review boards at study sites and was conducted in accordance with the Declaration of Helsinki, the International Conference on Harmonisation Good Clinical Practice guideline, and the applicable local laws and regulatory requirements in Japan. Parents or guardians of all infants provided written informed consents before participation in the study.